Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

FDA accepts MK-3475 BLA for review in advanced melanoma

May 8, 2014

IDH1 gene mutation-specific vaccine developed for treatment of patients with glioma

May 8, 2014

Advaxis' immunotherapy product to enter clinic for pediatric bone cancer

May 6, 2014

FDA grants orphan drug designation to OncoMed's demcizumab for pancreatic cancer

May 5, 2014

ADXS-HPV receives FDA orphan drug designation for invasive cervical cancer

May 5, 2014

Roche and NCI present preclinical data for RG-7787

May 2, 2014

NKTT-320 activates immunostimulatory functions of human iNKTs

May 2, 2014

Novartis will not exercise option for rights to Transgene's TG-4010

April 29, 2014

First patient treated in a phase II study evaluating CV-301 in bladder cancer

April 29, 2014

Mologen reports data from safety trial of MGN-1703

April 29, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...